Pembrolizumab (KEYTRUDA®) significantly prolonged Overall Survival and progression-free Survival in Patients with metastatic non-small cell Lung Cancer without Squamous Epithelium-Histology

被引：0
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：243 / 243
页数：1
相关论文
共 50 条
[31]   Progression-Free Survival as a Surrogate Endpoint of Overall Survival in Patients With Metastatic Renal Cell Carcinoma [J].
Halabi, Susan ;
Rini, Brian ;
Escudier, Bernard ;
Stadler, Walter M. ;
Small, Eric J. .
CANCER, 2014, 120 (01) :52-60
[32]   Panitumumab significantly improves progression-free survival in patients with metastatic colorectal cancer [J].
Van Cutsem, E. ;
Peeters, M. ;
Siena, S. ;
Humblet, Y. ;
Hendisz, A. ;
Neyns, B. ;
Canon, J. ;
Van Laethem, J. ;
Maurel, J. ;
Richardson, G. .
ANNALS OF ONCOLOGY, 2006, 17 :27-27
[33]   Association between Thyroid Dysfunction and Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Received Nivolumab [J].
Funazo, T. ;
Ozasa, H. ;
Nomizo, T. ;
Yasuda, Y. ;
Tsuji, T. ;
Yoshida, H. ;
Sakamori, Y. ;
Nagai, H. ;
Hirai, T. ;
Kim, Y. .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S2421-S2422
[34]   Baseline systemic inflammatory immune index may predict overall survival and progression-free survival in patients with non-small cell lung cancer patients on immune checkpoint inhibitors. [J].
Palmer, John P. ;
Cao, Yenong ;
Ibrahim, Samer ;
Dhawan, Natasha ;
Afzal, Muhammad Zubair ;
Shirai, Keisuke .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[35]   Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk [J].
He, Bing-Xi ;
Zhong, Yi-Fan ;
Zhu, Yong-Bei ;
Deng, Jia-Jun ;
Fang, Meng-Jie ;
She, Yun-Lang ;
Wang, Ting-Ting ;
Yang, Yang ;
Sun, Xi-Wen ;
Belluomini, Lorenzo ;
Watanabe, Satoshi ;
Dong, Di ;
Tian, Jie ;
Xie, Dong .
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (04) :670-+
[36]   Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer [J].
Aboshi, Masayuki ;
Kaneko, Masayuki ;
Narukawa, Mamoru .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (05) :839-848
[37]   Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis [J].
Sohn, H. S. ;
Kwon, J. -W. ;
Shin, S. ;
Kim, H. -S. ;
Kim, H. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (06) :661-671
[38]   SIMULATION AND COMPARISON OF PROGRESSION-FREE SURVIVAL (PFS) AMONG PATIENTS WITH NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) RECEIVING SEQUENTIAL THERAPY [J].
Chouaid, C. ;
Walzer, S. ;
Lister, J. ;
Gultyaev, D. ;
Vergnenegre, A. ;
de Marinis, F. ;
Meng, J. ;
de Castro, J. ;
Crott, R. ;
Kleman, M. ;
Ngoh, C. A. .
VALUE IN HEALTH, 2014, 17 (03) :A70-A70
[39]   Correlations between overall response rate, progression-free survival and overall survival in refractory small cell lung cancer treated with lurbinectedin [J].
Wasifuddin, Mustafa ;
Ilerhunmwuwa, Nosakhare Paul ;
Hakobyan, Narek ;
Tahir, Muhammad ;
Abowali, Hesham ;
Avezbakiyev, Boris .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[40]   META-ANALYSIS OF PROGRESSION-FREE SURVIVAL AND OBJECTIVE RESPONSE RATE AS PREDICTORS OF OVERALL SURVIVAL IN LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER [J].
Turner, Evadne J. ;
Mccloud, Philip ;
Germanos, Peter ;
Dehle, Francis ;
Norris, Sarah ;
Tan, Jonathon ;
Mitchell, Paul L. .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 :S243-S244
12345